BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 45 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,745,106 | -10.1% | 52,257,000 | -27.2% | 8.72% | +110.3% |
| Q2 2023 | $44,221,686 | +59.8% | 71,757,000 | +65.8% | 4.15% | -10.4% |
| Q1 2023 | $27,670,133 | +64.8% | 43,287,000 | 0.0% | 4.63% | +77.6% |
| Q4 2022 | $16,786,915 | -12.3% | 43,287,000 | 0.0% | 2.61% | +5.1% |
| Q3 2022 | $19,142,000 | -31.6% | 43,287,000 | -37.7% | 2.48% | +74.7% |
| Q2 2022 | $27,974,000 | -12.0% | 69,500,000 | +5.5% | 1.42% | -4.2% |
| Q1 2022 | $31,800,000 | – | 65,894,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INHERENT GROUP, LP | 39,500,000 | $19,370,000 | 3.63% |
| Athyrium Capital Management, LP | 20,000,000 | $9,682,000 | 3.44% |
| Diameter Capital Partners LP | 65,894,000 | $31,800,000 | 1.48% |
| Affinity Asset Advisors, LLC | 10,000,000 | $4,680,000 | 0.75% |
| Context Capital Management, LLC | 22,958 | $11,209,000 | 0.73% |
| DeepCurrents Investment Group LLC | 39,355,000 | $18,879,000 | 0.59% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $2,373,000 | 0.53% |
| Aequim Alternative Investments LP | 35,000,000 | $16,380,000 | 0.43% |
| Antara Capital LP | 25,750,000 | $12,246,000 | 0.37% |
| ARISTEIA CAPITAL, L.L.C. | 31,816,000 | $15,472,000 | 0.28% |